Hypoxia-inducible factor 1 and its role in viral carcinogenesis

Virology

Volumn 456-457, Issue 1, 2014, Pages 370-383

  Cuninghame, Sean ^a,b   Jackson, Robert ^a,b   Zehbe, Ingeborg ^a,b  

^a Thunder Bay Regional Research Institute   (Canada)

^b LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Angiogenesis; HIF 1; Invasion; Metabolism; Metastasis; Oncoviruses; Tumor microenvironment

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ANGIOGENESIS; E6 GENE; E7 GENE; EBV GENE; ENZYME ACTIVATION; EPSTEIN BARR VIRUS; HBX GENE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES VIRUS; HIF1A GENE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN T CELL LEUKEMIA VIRUS 1; KAPOSIS SARCOMA ASSOCIATED HERPES VIRUS; LMP1 GENE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT; UPREGULATION; VIRUS ACTIVATION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS ONCOGENE;

ANGIOGENESIS; HIF-1; INVASION; METABOLISM; METASTASIS; ONCOVIRUSES; TUMOR MICROENVIRONMENT;

CARCINOGENESIS; CELL TRANSFORMATION, VIRAL; DNA VIRUSES; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; RNA VIRUSES; TRANSCRIPTION, GENETIC;

EID: 84901596453     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.02.027     Document Type: Review

References (189)

1. Abe M., Koga H., Yoshida T., Masuda H., Iwamoto H., Sakata M., Hanada S., Nakamura T., Taniguchi E., Kawaguchi T., Yano H., Torimura T., Ueno T., Sata M. Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor-κB/hypoxia-inducible factor-1α axis under hypoxic conditions. Hepatol. Res. 2012, 42:591-600.
2. Acloque H., Thiery J.P., Nieto M.A. The physiology and pathology of the EMT. EMBO Rep. 2008, 9:322-326.
3. Agani F., Jiang B.H. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer. Curr. Cancer Drug Targets 2013, 13:245-251.
4. Arzumanyan A., Reis H.M., Feitelson M.A. Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma. Nat. Rev. Cancer 2013, 13:123-135.
5. Bais C., Santomasso B., Coso O., Arvanitakis L., Raaka E.G., Gutkind J.S., Asch A.S., Cesarman E., Gerhengorn M.C., Mesri E.A. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998, 391:86-89.
6. Bais C., Van Geelen A., Eroles P., Mutlu A., Chiozzini C., Dias S., Silverstein R.L., Rafii S., Mesri E.A. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/KDR. Cancer Cell 2003, 3:131-143.
7. Baritaki S., Sifakis S., Huerta-Yepez S., Neonakis I.K., Soufla G., Bonavida B., Spandidos D.A. Overexpression of VEGF and TGF-β1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection. Int. J. Oncol. 2007, 31:69-79.
8. Bersten D.C., Sullivan A.E., Peet D.J., Whitelaw M.L. bHLH-PAS proteins in cancer. Nat. Rev. Cancer 2013, 13:827-841.
9. Benn J., Schneider R.J. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc. Natl. Acad. Sci. USA 1995, 92:11215-11219.
10. BelAiba R.S., Bonello S., Zähringer C., Schmidt S., Hess J., Kietzmann T., Görlach A. Hypoxia up-regulates hypoxia-inducible factor-1α transcription by involving phosphatidylinositol 3-kinase and nuclear factor κB in pulmonary artery smooth muscle cells. Mol. Biol. Cell 2007, 18:4691-4697.
11. Bequet-Romero M., López-Ocejo O. Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins. Biochem. Biophys. Res. Commun. 2000, 277:55-61.
12. Berumen J., Ordoñez R.M., Lazcano E., Salmeron J., Galvan S.C., Estrada R.A., Yunes E., Garcia-Carranca A., Gonzalez-Lira G., Madrigal-de la Campa A. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 2001, 93:1325-1330.
13. Bodily J.M., Mehta K.P., Laimins L.A. Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases. Cancer Res. 2011, 71:1187-1195.
14. Boyer S.N., Wazer D.E., Band V. E7 Protein of human papillomavirus 16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996, 56:4620-4624.
15. Branca M., Giorgi C., Santini D., Di Bonito L., Ciotti M., Benedetto A., Paba A., Costa S., Bonifacio D., Di Bonito P., Accardi L., Favalli C., Syrjänen K. Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer. J. Clin. Pathol. 2006, 59:40-47.
16. Brand K.A., Hermfisse U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J. 1997, 11:388-395.
17. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294:1337-1340.
18. Buck M.R., Karustis D.G., Day N.A., Honn K.V., Sloane B.F. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem. J. 1992, 282:273-278.
19. Bui M.H., Seligson D., Han K.R., Pantuck A.J., Dorey F.J., Huang Y., Horvath S., Leibovich B.C., Chopra S., Liao S.-Y., Stanbridge E., Lerman M.I., Palotie A., Figlin R.A., Belldegrun A.S. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin. Cancer Res. 2003, 9:802-811.
20. Cai Q.L., Knight J.S., Verma S.C., Zald P., Robertson E.S. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog. 2006, 2:e116.
21. Cai Q., Lan K., Verma S.C., Si H., Lin D., Robertson E.S. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1α to upregulate RTA expression during hypoxia: latency control under low oxygen conditions. J. Virol. 2006, 80:7965-7975.
22. Cai Q., Murakami M., Si H., Robertson E.S. A potential α-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1α in normoxia. J. Virol. 2007, 81:10413-10423.
23. Cardeal L.B.D.S., Brohem C.A., Corrêa T.C.S., Winnischofer S.M.B., Nakano F., Boccardo E., Villa L.L., Sogayar M.C., Maria-Engler S.S. Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochem. Cell Biol. 2006, 84:713-719.
24. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
25. Carroll P.A., Kenerson H.L., Yeung R.S., Lagunoff M. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors. J. Virol. 2006, 80:10802-10812.
26. 2 sensing. J. Biol. Chem. 2000, 275:25130-25138.
27. Chiche J., Ilc K., Laferrière J., Trottier E., Dayan F., Mazure N.M., Brhaimi-Horn C., Pouysségur J. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 2009, 69:358-368.
28. Choi J.Y., Jang Y.S., Min S.Y., Song J.Y. Overexpression of MMP-9 and HIF-1α in breast cancer cells under hypoxic conditions. J. Breast Cancer 2011, 14:88-95.
29. Cheng J., Kang X., Zhang S., Yeh E.T. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 2007, 131:584-595.
30. Christiansen J.J., Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006, 66:8319-8326.
31. Chua H.L., Bhat-Nakshatri P., Clare S.E., Morimiya A., Badve S., Nakshatri H. NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 2006, 26:711-724.
32. Chung T.W., Lee Y.C., Kim C.H. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J. 2004, 18:1123-1125.
33. Cornali E., Zietz C., Benelli R., Weninger W., Masiello L., Breier G., Tschachler E., Albini A., Stürzl M. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am. J. Pathol. 1996, 149:1851-1869.
34. Coussens L.M., Tinkle C.L., Hanahan D., Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000, 103:481-490.
35. D'Costa Z.J., Jolly C., Androphy E.J., Mercer A., Matthews C.M., Hibma M.H. Transcriptional repression of E-cadherin by human papillomavirus type 16 E6. PloS One 2012, 7:e48954.
36. Darekar S., Georgiou K., Yurchenko M., Yenamandra S.P., Chachami G., Simos G., Klein G., Kashuba E. Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect. PloS One 2012, 7:e42072.
37. Depping R., Steinhoff A., Schindler S.G., Freidrich B., Fagerlund R., Metzen E., Hartmann E., Köhler M. Nuclear translocation of hypoxia-inducible factors (HIFs): Involvement of the classical α/β importin pathway. BBA - Mol. Cell. Res. 2008, 1783:394-404.
38. de Martel C., Ferlay J., Franceschi S., Vignat J., Bray F., Forman D., Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012, 13:607-615.
39. Demidenko Z.N., Blagosklonny M.V. The purpose of the HIF-1/PHD feedback loop: to limit mTOR-induced HIF-1α. Cell Cycle 2011, 10:1557-1562.
40. Diamond D.L., Syder A.J., Jacobs J.M., Sorensen C.M., Walter K.A., Proll S.C., McDermott J.E., Gritsenko M.A., Zhang Q., Zhao R., Metz T.O., Camp D.G., Waters K.M., Smith R.D., Rice C.M., Katze M.G. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 2010, 6:e1000719.
41. Dolado I., Swat A., Ajenjo N., De Vita G., Cuadrado A., Nebreda A.R. p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 2007, 11:191-205.
42. Elson D.A., Ryan H.E., Snow J.W., Johnson R., Arbeit J.M. Coordinate up-regulation of hypoxia inducible factor (HIF)-1α and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res. 2000, 60:6189-6195.
43. Estrella V., Chen T., Lloyd M., Wojtkowiak J., Cornnell H.H., Ibrahim-Hashim A., Bailey K., Balagurunathan Y., Rothberg J.M., Sloane B.F., Johnson J., Gatenby R.A., Gillies R.J. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 2013, 73:1524-1535.
44. El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012, 142:1264-1273.
45. Fallot G., Neuveut C., Buendia M.A. Diverse roles of hepatitis B virus in liver cancer. Curr. Opin. Virol. 2012, 2:467-473.
46. Fernández-Figueras M.T., Puig L., Musulén E., Gilaberte M., Lerma E., Serrano S., Ferrándiz C., Ariza A. Expression profiles associated with aggressive behavior in Merkel cell carcinoma. Mod. Pathol. 2006, 20:90-101.
47. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
48. Forsythe J.A., Jiang B.H., Iyer N.V., Agani F., Leung S.W., Koos R.D., Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 1996, 16:4604-4613.
49. Friborg J., Kong W., Hottiger M.O., Nabel G.J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 1999, 402:889-894.
50. Fujiwara S., Nakagawa K., Harada H., Nagato S., Furukawa K., Teraoka M., Seno T., Oka K., Iwata S., Ohnishi T. Silencing hypoxia-inducible factor-1α inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int. J. Oncol. 2007, 30:793-802.
51. Garber K. Energy boost: the Warburg effect returns in a new theory of cancer. J. Natl. Cancer Inst. 2004, 96:1805-1806.
52. Gasperini P., Espigol-Frigole G., McCormick P.J., Salvucci O., Maric D., Uldrick T.S., Polizzotto M.N., Yarchoan R., Tosato G. Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling. Cancer Res. 2012, 72:1157-1169.
53. Grassmann R., Aboud M., Jeang K.T. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005, 24:5976-5985.
54. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
55. Haque M., Davis D.A., Wang V., Widmer I., Yarchoan R. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia. J. Virol. 2003, 77:6761-6768.
56. Holotnakova T., Tylkova L., Takacova M., Kopacek J., Petrik J., Pastorekova S., Pastorek J. Role of the HBx oncoprotein in carbonic anhydrase 9 induction. J. Med. Virol. 2010, 82:32-40.
57. Horikawa T., Yoshizaki T., Sheen T.S., Lee S.Y., Furukawa M. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 2000, 89:715-723.
58. Horikawa T., Yang J., Kondo S., Yoshizaki T., Joab I., Furukawa M., Pagano J.S. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 2007, 67:1970-1978.
59. Horikawa T., Yoshizaki T., Kondo S., Furukawa M., Kaizaki Y., Pagano J.S. Epstein-Barr virus latent membrane protein 1 induces snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br. J. Cancer 2011, 104:1160-1167.
60. Humar R., Kiefer F.N., Berns H., Resink T.J., Battegay E.J. Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J. 2002, 16:771-780.
61. Higgins D.F., Kimura K., Bernhardt W.M., Shrimanker N., Akai Y., Hohenstein B., Saito Y., Johnson R.S., Kretzler M., Cohen C.D., Eckardt K.-U., Iwano M., Haase V.H. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J. Clin. Invest. 2007, 117:3810-3820.
62. Hui E.P., Chan A.T.C., Pezzella F., Turley H., To K.-F., Poon T.C.W., Zee B., Mo F., Teo P.M.L., Huang D.P., Gatter K.C., Johnson P.J., Harris A.L. Coexpression of hypoxia-inducible factors 1α and 2α, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin. Cancer Res. 2002, 8:2595-2604.
63. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev. 1998, 12:149-162.
64. Jeong S.J., Dasgupta A., Jung K.J., Um J.H., Burke A., Park H.U., Brady J.N. PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells. Virology 2008, 370:264-272.
65. Jham B.C., Ma T., Hu J., Chaisuparat R., Friedman E.R., Pandolfi P.P., Schneider A., Sodhi A., Montaner S. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma. PLoS One 2011, 6:e19103.
66. Jiang B.H., Jiang G., Zheng J.Z., Lu Z., Hunter T., Vogt P.K. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 2001, 12:363-369.
67. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
68. Kalla M., Hammerschmidt W. Human B cells on their route to latent infection-early but transient expression of lytic genes of Epstein-Barr virus. EJCB 2012, 91:65-69.
69. Kato H., Tamamizu-Kato S., Shibasaki F. Histone deacetylase 7 associates with hypoxia-inducible factor 1α and increases transcriptional activity. J. Biol. Chem. 2004, 279:41966-41974.
70. Kim C.M., Koike K., Saito I., Miyamura T., Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991, 351:317-320.
71. Kim J.W., Dang C.V. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 2006, 66:8927-8930.
72. Klingelhutz A.J., Foster S.C., McDougall J.K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996, 380:79-82.
73. Kong X., Lin Z., Liang D., Fath D., Sang N., Caro J. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1α. Mol. Cell. Biol. 2006, 26:2019-2028.
74. Kondo S., Seo S.Y., Yoshizaki T., Wakisaka N., Furukawa M., Joab I., Jang K.L., Pagano J.S. EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1α through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells. Cancer Res. 2006, 66:9870-9877.
75. Kondoh H., Lleonart M.E., Gil J., Wang J., Degan P., Peters G., Martinez D., Carnero A., Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res. 2005, 65:177-185.
76. Krieg M., Haas R., Brauch H., Acker T., Flamme I., Plate K.H. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 2000, 19:5435-5443.
77. Krishna S.M., James S., Balaram P. Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status. Virus Res. 2006, 115:85-90.
78. Krishnamachary B., Berg-Dixon S., Kelly B., Agani F., Feldser D., Ferreira G., Iyer N., LaRusch J., Pak B., Taghavi P., Semenza G.L. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 2003, 63:1138-1143.
79. Kuo W.H., Chou F.P., Lu S.C., Chu S.C., Hsieh Y.S. Significant differences in serum activities of matrix metalloproteinase-2 and-9 between HCV-and HBV-infected patients and carriers. Clin. Chim. Acta 2000, 294:157-168.
80. Lando D., Peet D.J., Whelan D.A., Gormon J.J., Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 2002, 295:858-861.
81. Laughner E., Taghavi P., Chiles K., Mahon P.C., Semenza G.L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 2001, 21:3995-4004.
82. Le Buanec H., D'Anna R., Lachgar A., Zagury J.F., Bernard J., Ittelé D.D., d'Alessio P., Hallez S., Giannouli C., Burny A., Bizzini B., Gallo R.C., Zagury D. HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes. Biomed. Pharmacother. 1999, 53:424-431.
83. Lee S.W., Lee Y.M., Bae S.K., Murakami S., Yun Y., Kim K.W. Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis. Biochem. Biophys. Res. Commun. 2000, 268:456-461.
84. Lee D.F., Kuo H.P., Chen C.T., Hsu J.M., Chou C.K., Wei Y., Sun H.L., Li L.Y., Ping B., Huang W.C., He X., Hung J.Y., Lai C.C., Ding Q., Su J.L., Yang J.Y., Sahin A.A., Hortobagyi G.N., Tsai F.J., Tsai C.H., Hung M.C. IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 2007, 130:440-455.
85. Lee W.Y., Huang S.C., Hsu K.F., Tzeng C.C., Shen W.L. Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence. Gynecol. Oncol. 2008, 108:377-384.
86. Li G., He L., Zhang E., Shi J., Zhang Q., Le A.D., Zhou K., Tang X. Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1α and VEGF expression in non-small cell lung cancer cells. Cancer Lett. 2011, 311:160-170.
87. Lim J.H., Lee Y.M., Chun Y.S., Chen J., Kim J.E., Park J.W. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol. Cell 2010, 38:864-878.
88. Lichtinghagen R., Bahr M.J., Wehmeier M., Michels D., Haberkorn C.I., Arndt B., Flemming P., Manns M.P., Boeker K.H.W. Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin. Sci. 2003, 105:373-382.
89. Lu Z.H., Wright J.D., Belt B., Cardiff R.D., Arbeit J.M. Hypoxia-inducible factor-1 facilitates cervical cancer progression in human papillomavirus type 16 transgenic mice. Am. J. Pathol. 2007, 171:667-681.
90. Liu C., Shi Y., Han Z., Pan Y., Liu N., Han S., Chen Y., Lan M., Qiao T., Fan D. Suppression of the dual-specificity phosphatase MKP-1 enhances HIF-1 trans-activation and increases expression of EPO. Biochem. Biophys. Res. Commun. 2003, 312:780-786.
91. Liu J., Ahiekpor A., Li L., Li X., Arbuthnot P., Kew M., Feitelson M.A. Increased expression of ErbB-2 in liver is associated with hepatitis B× antigen and shorter survival in patients with liver cancer. Int. J. Cancer 2009, 125:1894-1901.
92. Liu L.P., Liang H.F., Chen X.P., Zhang W.G., Yang S.L., Xu T., Ren L. The role of NF-κB in Hepatitis B virus X protein-mediated upregulation of VEGF and MMPs. Cancer Invest. 2010, 28:443-451.
93. Lo K.W., Lo Y.D., Leung S.F., Tsang Y.S., Chan L.Y., Johnson P.J., Hjelm N.M., Lee J.C.K., Huang D.P. Analysis of cell-free Epstein-Barr virus-associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin. Chem. 1999, 45:1292-1294.
94. López-Ocejo O., Viloria-Petit A., Bequet-Romero M., Mukhopadhyay D., Rak J., Kerbel R.S. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 2000, 19:4611-4620.
95. Lu H., Forbes R.A., Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J. Biol. Chem. 2002, 277:23111-23115.
96. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., Teruya-Feldstein J., Reinhardt F., Onder T.T., Valastyan S., Westermann F., Speleman F., Vandesompele J., Weinberg R.A. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 2010, 12:247-256.
97. Mas V.R., Maluf D.G., Archer K.J., Yanek K.C., Fisher R.A. Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation. Transplantation 2007, 84:1262-1271.
98. Majumder P.K., Febbo P.G., Bikoff R., Berger R., Xue Q., McMahon L.M., Manola J., Brugarolas J., McDonnell T.J., Golub T.R., Loda M., Lane H.A., Sellers W.R. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat. Med. 2004, 10:594-601.
99. Masood R., Cai J., Zheng T., Smith D.L., Naidu Y., Gill P.S. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc. Natl. Acad. Sci. USA 1997, 94:979-984.
100. Matthews K., Leong C.M., Baxter L., Inglis E., Yun K., Bäckström B.T., Doorbar J., Hibma M. Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J. Virol. 2003, 77:8378-8385.
101. McGivern D.R., Lemon S.M. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 2011, 30:1969-1983.
102. Mesri E.A., Cesarman E., Boshoff C. Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer 2010, 10:707-719.
103. Minet E., Ernest I., Michel G., Roland I., Remacle J., Raes M., Michiels C. HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5'-UTR. Biochem. Biophys. Res. Commun. 1999, 261:534-540.
104. Montaner S., Sodhi A., Pece S., Mesri E.A., Gutkind J.S. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res. 2001, 61:2641-2648.
105. Moon E.J., Jeong C.H., Jeong J.W., Kim K.R., Yu D.Y., Murakami S., Kim C.W., Kim K.W. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1α. FASEB J. 2004, 18:382-384.
106. Moore P.S., Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer 2010, 10:878-889.
107. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 1998, 4:1065-1067.
108. Murono S., Inoue H., Tanabe T., Joab I., Yoshizaki T., Furukawa M., Pagano J.S. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc. Natl. Acad. Sci. USA 2001, 98:6905-6910.
109. Niu G., Briggs J., Deng J., Ma Y., Lee H., Kortylewski M., Kujawski M., Kay H., Cress W.D., Jove R., Yu H. Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1α RNA expression in both tumor cells and tumor-associated myeloid cells. Mol. Cancer Res. 2008, 6:1099-1105.
110. Nakamura M., Bodily J.M., Beglin M., Kyo S., Inoue M., Laimins L.A. Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses. Virology 2009, 387:442-448.
111. Nasimuzzaman M., Waris G., Mikolon D., Stupack D.G., Siddiqui A. Hepatitis C virus stabilizes hypoxia-inducible factor 1α and stimulates the synthesis of vascular endothelial growth factor. J. Virol. 2007, 81:10249-10257.
112. Niccoli S., Abraham S., Richard C., Zehbe I. The Asian-American E6 variant protein of human papillomavirus 16 alone is sufficient to promote immortalization, transformation, and migration of primary human foreskin keratinocytes. J. Virol. 2012, 86:12384-12396.
113. Noch E., Khalili K. Oncogenic viruses and tumor glucose metabolism: like kids in a candy store. Mol. Cancer Ther. 2012, 11:14-23.
114. Núñez O., Fernández-Martínez A., Majano P.L., Apolinario A., Gómez-Gonzalo M., Benedicto I., López-Cabrera M., Boscá L., Clemente G., García-Monzón C., Martín-Sanz P. Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins. Gut 2004, 53:1665-1672.
115. Oka H., Shiozaki H., Kobayashi K., Inoue M., Tahara H., Kobayashi T., Takatsuka Y., Matsuyoshi N., Hirano S., Takeichi M., Mori T. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 1993, 53:1696-1701.
116. Onder T.T., Gupta P.B., Mani S.A., Yang J., Lander E.S., Weinberg R.A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008, 68:3645-3654.
117. O'Neil J.D., Owen T.J., Wood V.H., Date K.L., Valentine R., Chukwuma M.B., Arrand J.R., Dawson C.W., Young L.S. Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J. Gen. Virol. 2008, 89:2833-2842.
118. Parks S.K., Chiche J., Pouysségur J. Disrupting proton dynamics and energy metabolism for cancer therapy. Nat. Rev. Cancer 2013, 13:611-623.
119. Peloponese J.M., Jeang K.T. Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J. Biol. Chem. 2006, 281:8927-8938.
120. Potter C., Harris A.L. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle 2004, 3:159-162.
121. Qian D.Z., Kachhap S.K., Collis S.J., Verheul H.M., Carducci M.A., Atadja P., Pili R. Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α. Cancer Res. 2006, 66:8814-8821.
122. Qian L.W., Xie J., Ye F., Gao S.J. Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases. J. Virol. 2007, 81:7001-7010.
123. Qi M., Elion E.A. MAP kinase pathways. J. Cell Sci. 2005, 118:3569-3572.
124. Radkov S.A., Kellam P., Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 2000, 6:1121-1127.
125. Ramos da Silva S., Elgui de Oliveira D. HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies. Cancer Lett. 2011, 305:175-185.
126. Ravi R., Mookerjee B., Bhujwalla Z.M., Sutter C.H., Artemov D., Zeng Q., Dillehay L.E., Madan A., Semenza G.L., Bedi A. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev. 2000, 14:34-44.
127. Ray R.B., Steele R., Meyer K., Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J. Biol. Chem. 1997, 272:10983-10986.
128. Richard D.E., Berra E., Gothie E., Roux D., Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 1999, 274:32631-32637.
129. Ripoli M., D'Aprile A., Quarato G., Sarasin-Filipowicz M., Gouttenoire J., Scrima R., Cela O., Boffoli D., Heim M.H., Moradpour D., Capitanio N., Piccoli C. Hepatitis C virus-linked mitochondrial dysfunction promotes hypoxia-inducible factor 1α-mediated glycolytic adaptation. J. Virol. 2010, 84:647-660.
130. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet Johnson R.S., Haddad G.G., Karin M. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 2008, 453:807-811.
131. Rivas C., Thlick A.E., Parravicini C., Moore P.S., Chang Y. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J. Virol. 2001, 75:429-438.
132. Robey I.F., Baggett B.K., Kirkpatrick N.D., Roe D.J., Dosescu J., Sloane B.F., Hashim A.I., Morse D.L., Raghunand N., Gatenby R.A., Gillies R.J. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 2009, 69:2260-2268.
133. Rofstad E.K., Mathiesen B., Kindem K., Galappathi K. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 2006, 66:6699-6707.
134. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y., Moore P.S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 1996, 93:14862-14867.
135. Salcedo X., Medina J., Sanz-Cameno P., García-Buey L., Martín-Vilchez S., Borque M.J., López-Cabrera M., Moreno-Otero R. The potential of angiogenesis soluble markers in chronic hepatitis C. Hepatology 2005, 42:696-701.
136. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75:495-505.
137. Schultz B.E., Chan S.I. Structures and proton-pumping strategies of mitochondrial respiratory enzymes. Annu. Rev. Biophys. Biomol. Struct. 2001, 30:23-65.
138. Schipper J.H., Frixen U.H., Behrens J., Unger A., Jahnke K., Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 1991, 51:6328-6337.
139. Semenza G.L., Roth P.H., Fang H.M., Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 1994, 269:23757-23763.
140. Semenza G.L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 2000, 88:1474-1480.
141. 2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 2001, 107:1-3.
142. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3:721-732.
143. Semenza G.L. HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J. Bioenerg. Biomembr. 2007, 39:231-234.
144. Semenza G.L. HIF-1: upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev. 2010, 20:51-56.
145. Semenza G.L. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci. 2012, 33:207-214.
146. Shaw R.J. Glucose metabolism and cancer. Curr. Opin. Cell Biol. 2006, 18:598-608.
147. Shin Y.C., Joo C.H., Gack M.U., Lee H.R., Jung J.U. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression. Cancer Res. 2008, 68:1751-1759.
148. Sodhi A., Montaner S., Patel V., Zohar M., Bais C., Mesri E.A., Gutkind J.S. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1α. Cancer Res. 2000, 60:4873-4880.
149. Son Y., Cheong Y.K., Kim N.H., Chung H.T., Kang D.G., Pae H.O. Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?. J. Signal Transduct. 2011, 2011:6.
150. Sperandio S., Fortin J., Sasik R., Robitaille L., Corbeil J., de Belle I. The transcription factor Egr1 regulates the HIF-1α gene during hypoxia. Mol. Carcinogen. 2009, 48:38-44.
151. Steeg P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 2006, 12:895-904.
152. Stroka D.M., Burkhardt T., Desbaillets I., Wenger R.H., Neil D.A.H., Bauer C., Gassmann M., Candinas D. FASEB J. 2001, 15:2445-2453.
153. Suzuki H., Tomida A., Tsuruo T. Dephosphorylated hypoxia-inducible factor 1alphaas a mediator of p53-dependent apoptosis during hypoxia. Oncogene 2001, 20:5779-5788.
154. Swinson D.E., Jones J.L., Richardson D., Wykoff C., Turley H., Pastorek J., Taub N., Harris A.L., O'Byrne K.J. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J. Clin. Oncol. 2003, 21:473-482.
155. Švastová E., Hulíková A., Rafajová M., Zat'ovičová M., Gibadulinová A., Casini A., Cecchi A., Scozzafava A., Supuran C.T., Pastorek J., Pastoreková S. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 2004, 577:439-445.
156. Tardif K.D., Waris G., Siddiqui A. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol. 2005, 13:159-163.
157. Thompson M.P., Kurzrock R. Epstein-Barr virus and cancer. Clin. Cancer Res. 2004, 10:803-821.
158. Tang X., Zhang Q., Nishitani J., Brown J., Shi S., Le A.D. Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1α protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin. Cancer Res. 2007, 13:2568-2576.
159. Thomas G.V., Tran C., Mellinghoff I.K., Welsbie D.S., Chan E., Fueger B., Czernin J., Sawyers C.L. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nat. Med. 2005, 12:122-127.
160. Tomita M., Semenza G., Michiels C., Matsuda T., Uchihara J., Okudaira T., Tanaka Y., Taira N., Ohshiro K., Mori N. Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells. Biochem. J. 2007, 406:317-323.
161. Turk V., Turk B., Turk D. Lysosomal cysteine proteases: facts and opportunities. EMBO J. 2001, 20:4629-4633.
162. Umbas R., Isaacs W.B., Bringuier P.P., Schaafsma H.E., Karthaus H.F., Oosterhof G.O., Debruyne F.M., Schalken J.A. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res. 1994, 54:3929-3933.
163. van Uden P., Kenneth N.S., Rocha S. Regulation of hypoxia-inducible factor-1α by NF-κB. Biochem. J. 2008, 412:477-484.
164. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
165. Wakisaka N., Pagano J.S. Epstein-Barr virus induces invasion and metastasis factors. Anticancer Res. 2003, 23:2133-2138.
166. Wakisaka N., Kondo S., Yoshizaki T., Murono S., Furukawa M., Pagano J.S. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1α. Mol. Cell. Biol. 2004, 24:5223-5234.
167. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 1995, 92:5510-5514.
168. Wang X., Martindale J., Liu Y., Holbrook N. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. 1998, 333:291-300.
169. Wang L., Wakisaka N., Tomlinson C.C., DeWire S.M., Krall S., Pagano J.S., Damania B. The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res. 2004, 64:2774-2781.
170. Warburg O., Wind F., Negelein E. The metabolism of tumors in the body. J. Gen. Physiol. 1927, 8:519-530.
171. Wen K.W., Damania B. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett. 2010, 289:140-150.
172. Wenger R.H., Rolfs A., Marti H.H., Guenet J.-L., Gassmann M. Nucleotide sequence, chromosomal assignment and mRNA expression of mouse hypoxia-inducible factor-1 α. Biochem. Biophys. Res. Commun. 1996, 223:54-59.
173. Wenger R.H., Kvietikova I., Rolfs A., Gassmann M., Marti H.H. Hypoxia-inducible factor-1α is regulated at the post mRNA level. Kidney Int. 1997, 51:560-563.
174. Wiener C.M., Booth G., Semenza G.L. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 1996, 225:485-488.
175. Wilson G.K., Brimacombe C.L., Rowe I.A., Reynolds G.M., Fletcher N.F., Stamataki Z., Bhoagi R.H., Simões M.L., Ashcroft M., Afford S.C., Mitry R.R., Dhawan A., Mee C.J., Hübscher S.G., Bafle P., McKeating J.A. A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration. J. Hepatol. 2012, 56:803-809.
176. Wise-Draper T.M., Wells S.I. Papillomavirus E6 and E7 proteins and their cellular targets. Front. Biosci. 2007, 13:1003-1017.
177. Yang M.H., Wu K.J. TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle 2008, 7:2090-2096.
178. Yang M.H., Chen C.L., Chau G.Y., Chiou S.H., Su C.W., Chou T.Y., Peng W.L., Wu J.C. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 2009, 50:1464-1474.
179. Yen C.J., Lin Y.J., Yen C.S., Tsai H.W., Tsai T.F., Chang K.Y., Chang T.T. Hepatitis B virus X protein upregulates mTOR signaling through IKKβ to increase cell proliferation and VEGF production in hepatocellular carcinoma. PLoS One 2012, 7:e41931.
180. Yoo Y.G., Oh S.H., Park E.S., Cho H., Lee N., Park H., Kim D.K., Yu D.Y., Seong J.K., Lee M.O. Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1α through activation of mitogen-activated protein kinase pathway. J. Biol. Chem. 2003, 278:39076-39084.
181. Yoo Y.G., Cho S., Park S., Lee M.O. The carboxy-terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia-inducible factor-1α. FEBS Lett. 2004, 577:121-126.
182. Yoo Y.G., Kong G., Lee M.O. Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1. EMBO J. 2006, 25:1231-1241.
183. Yoo Y.G., Na T.Y., Seo H.W., Seong J.K., Park C.K., Shin Y.K., Lee M.O. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008, 27:3405-3413.
184. Yoshizaki T., Sato H., Furukawa M., Pagano J.S. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc. Natl. Acad. Sci. USA 1998, 95:3621-3626.
185. Young L.S., Rickinson A.B. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 2004, 4:757-768.
186. Zehbe I., Wilander E., Delius H., Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998, 58:829-833.
187. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 1999, 59:5830-5835.
188. zur Hausen H., Schulte-Holthausen H., Klein G., Henle G., Henle W., Clifford P., Santesson L. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970, 228:1056-1058.
189. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2002, 2:342-350.